Literature DB >> 32822075

Disease Surveillance Investments and Administration: Limits to Information Value in Pakistan Polio Eradication.

Ryan P Scott1,2, Alison C Cullen1, Guillaume Chabot-Couture3.   

Abstract

In Pakistan, annual poliovirus investment decisions drive quantities of supplemental immunization campaigns districts receive. In this article, we assess whether increased spending on poliovirus surveillance is associated with greater likelihood of correctly identifying districts at high risk of polio with assignment of an elevated "risk ranking." We reviewed programmatic documents from Pakistan for the period from 2012-2017, recording whether districts had been classified as "high risk" or "low risk" in each year. Through document review, we developed a decision tree to describe the ranking decisions. Then, integrating data from the World Health Organization and Global Polio Eradication Initiative, we constructed a Bayesian decision network reflecting investments in polio surveillance and immunization campaigns, surveillance metrics, disease incidence, immunization rates, and occurrence of polio cases. We test these factors for statistical association with the outcome of interest-a change in risk rank between the beginning and the end of the one-year time period. We simulate different spending scenarios and predict their impact on district risk ranking in future time periods. We find that per district spending increases are associated with increased identification of cases of acute flaccid paralysis (AFP). However, the low specificity of AFP investment and the largely invariant ranking of district risk means that even large increases in surveillance spending are unlikely to promote major changes in risk rankings at the current stage of the Pakistan polio eradication campaign.
© 2020 The Authors. Risk Analysis published by Wiley Periodicals LLC on behalf of Society for Risk Analysis.

Entities:  

Keywords:  Disease surveillance; polio; value of information

Mesh:

Year:  2020        PMID: 32822075      PMCID: PMC7984073          DOI: 10.1111/risa.13580

Source DB:  PubMed          Journal:  Risk Anal        ISSN: 0272-4332            Impact factor:   4.000


  36 in total

Review 1.  Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review.

Authors:  P A Patriarca; P F Wright; T J John
Journal:  Rev Infect Dis       Date:  1991 Sep-Oct

2.  New strategies for the elimination of polio from India.

Authors:  Nicholas C Grassly; Christophe Fraser; Jay Wenger; Jagadish M Deshpande; Roland W Sutter; David L Heymann; R Bruce Aylward
Journal:  Science       Date:  2006-11-17       Impact factor: 47.728

Review 3.  A Primer on Bayesian Decision Analysis With an Application to a Kidney Transplant Decision.

Authors:  Richard Neapolitan; Xia Jiang; Daniela P Ladner; Bruce Kaplan
Journal:  Transplantation       Date:  2016-03       Impact factor: 4.939

4.  World Health Organization regional assessments of the risks of poliovirus outbreaks.

Authors:  Sara A Lowther; Sigrun Roesel; Patrick O'Connor; Mauricio Landaverde; George Oblapenko; Sergei Deshevoi; Goel Ajay; Ann Buff; Hala Safwat; Mbaye Salla; Rudi Tangermann; Nino Khetsuriani; Rebecca Martin; Steven Wassilak
Journal:  Risk Anal       Date:  2013-03-23       Impact factor: 4.000

5.  Insecurity, polio vaccination rates, and polio incidence in northwest Pakistan.

Authors:  Amol A Verma; Marcia P Jimenez; Rudolf H Tangermann; S V Subramanian; Fahad Razak
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-29       Impact factor: 11.205

Review 6.  From emergence to eradication: the epidemiology of poliomyelitis deconstructed.

Authors:  Neal Nathanson; Olen M Kew
Journal:  Am J Epidemiol       Date:  2010-10-26       Impact factor: 4.897

7.  The cost-effectiveness and value of information of three influenza vaccination dosing strategies for individuals with human immunodeficiency virus.

Authors:  Bohdan Nosyk; Behnam Sharif; Huiying Sun; Curtis Cooper; Aslam H Anis
Journal:  PLoS One       Date:  2011-12-06       Impact factor: 3.240

8.  Characterization of outbreak response strategies and potential vaccine stockpile needs for the polio endgame.

Authors:  Radboud J Duintjer Tebbens; Mark A Pallansch; Steven G F Wassilak; Stephen L Cochi; Kimberly M Thompson
Journal:  BMC Infect Dis       Date:  2016-03-24       Impact factor: 3.090

9.  Spatial model for risk prediction and sub-national prioritization to aid poliovirus eradication in Pakistan.

Authors:  Laina D Mercer; Rana M Safdar; Jamal Ahmed; Abdirahman Mahamud; M Muzaffar Khan; Sue Gerber; Aiden O'Leary; Mike Ryan; Frank Salet; Steve J Kroiss; Hil Lyons; Alexander Upfill-Brown; Guillaume Chabot-Couture
Journal:  BMC Med       Date:  2017-10-11       Impact factor: 8.775

10.  Characterising the costs of the Global Polio Laboratory Network: a survey-based analysis.

Authors:  Radboud J Duintjer Tebbens; Ousmane M Diop; Mark A Pallansch; M Steven Oberste; Kimberly M Thompson
Journal:  BMJ Open       Date:  2019-01-21       Impact factor: 2.692

View more
  3 in total

Review 1.  Mind the "Vaccine Fatigue".

Authors:  Zhaohui Su; Ali Cheshmehzangi; Dean McDonnell; Claudimar Pereira da Veiga; Yu-Tao Xiang
Journal:  Front Immunol       Date:  2022-03-10       Impact factor: 7.561

2.  Assessing Response Readiness to Health Emergencies: A Spatial Evaluation of Health and Socio-Economic Justice in Pakistan.

Authors:  Muhammad Sajjad; Syed Hassan Raza; Asad Abbas Shah
Journal:  Soc Indic Res       Date:  2022-04-25

3.  Modeling Poliovirus Surveillance and Immunization Campaign Quality Monitoring Costs for Pakistan and Afghanistan for 2019-2023.

Authors:  Dominika A Kalkowska; Mark A Pallansch; Stephen L Cochi; Kimberly M Thompson
Journal:  Open Forum Infect Dis       Date:  2021-05-23       Impact factor: 3.835

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.